OBIO Next Earnings Date Notes

— Orchestra BioMed Holdings (OBIO) is a biomedical innovation company that partners with established global medical device firms to advance high-impact therapies for cardiovascular diseases and other areas of unmet medical need. Their current core products in development include BackBeat Cardiac Neuromodulation Therapy (CNT) for hypertension, and Virtue Sirolimus AngioInfusion Balloon (SAB) for treating coronary artery disease – both with significant target patient populations and market potential. As a company at the clinical and early-commercialization stage, OBIO’s most relevant business metrics include progress and results in clinical trials, regulatory milestones & approvals, new or expanded strategic partnerships (such as with Medtronic), cash burn rate, and available liquidity to fund ongoing R&D. Pipeline updates and timelines for pivotal study readouts are key for investors listening to earnings calls. Revenue is currently limited due to the pre-commercial status of OBIO’s flagship products, so investor focus is better placed on clinical efficacy, partnership economics, and management guidance about the regulatory and commercialization pathway. Tracking these metrics will help you assess OBIO’s execution toward long-term growth & value creation. The next projected earnings date for OBIO is 3/30/2026 after close (stay tuned for a confirmed earnings date once announced).

OBIO Next Earnings Date FAQ

On this page we presented the OBIO Next Earnings Date information for Orchestra BioMed Hldgs along with recent past earnings dates. For Q3 of 2025, OBIO reported earnings of -0.400/share, with the earnings report taking place on 11/10/2025. For Q2 of 2025, OBIO reported earnings of -0.500/share, with the earnings report taking place on 8/12/2025. For Q1 of 2025, OBIO reported earnings of -0.490/share, with the earnings report taking place on 5/12/2025. For Q4 of 2024, OBIO reported earnings of -0.430/share, with the earnings report taking place on 3/31/2025. For Q3 of 2024, OBIO reported earnings of -0.410/share, with the earnings report taking place on 11/12/2024. Based on these past earnings dates, the projected next earnings date for OBIO is 3/30/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Orchestra BioMed Hldgs. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Orchestra BioMed Hldgs shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Orchestra BioMed Hldgs next earnings dates as well as any other stock out there in our coverage universe, to see when the next OBIO earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up OBIO's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the OBIO next earnings date.